CORRECTING and REPLACING One of Chicago’s Top Private Equity Firms, Red Arts Capital, Continues Growth By Adding Two Key Team Members
Christopher DeLetto and Indra Santhiapillai are joining the firm that ranked in the .9% of…
Christopher DeLetto and Indra Santhiapillai are joining the firm that ranked in the .9% of…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA comments on Brookline Bancorp, Inc.’s (NASDAQ: BRKL) (Brookline or the company) proposed…
MENLO PARK, Calif.–(BUSINESS WIRE)–$CYN #amrs—Cyngn (or the “Company”) (NASDAQ: CYN), a developer of innovative autonomous…
New York, NY, and Tel Aviv, ISRAEL, May 27, 2022 (GLOBE NEWSWIRE) — via NewMediaWire —Todos…
BUFFALO, N.Y., May 27, 2022 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a…
TEL AVIV, Israel, May 27, 2022 (GLOBE NEWSWIRE) — SciSparc Ltd. (NASDAQ: SPRC) (the “Company”…
Shaw’s donation will help support charities through the PGA TOUR Champions…
Toronto, Ontario–(Newsfile Corp. – May 27, 2022) – Canada Computational Unlimited Corp. (TSXV: SATO) (OTCQB: CCPU.F)…
The 6-month IFH Lab is a no-fee and no-equity program for 8 early stage startups…
JAKARTA, May 27, 2022 – (ACN Newswire) – The B20 Energy, Sustainability, and Climate (ESC)…
PENANG, Malaysia, May 27, 2022 – (ACN Newswire) – CNERGENZ Berhad (CNERGENZ), an established electronics…
LONDON / NEW YORK, May 27, 2022 – (ACN Newswire) – WARC, the global authority…
SAN FRANCISCO–(BUSINESS WIRE)–#cybersecurity–Members of the Messaging, Malware and Mobile Anti-Abuse Working Group (M3AAWG) will gather…
The ARM Institute’s RoboticsCareer.org national workforce resource has been internationally recognized with a Robotics Business…
IRVINE, Calif., May 27, 2022 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission…
EDISON, N.J., May 27, 2022 (GLOBE NEWSWIRE) — In the press release issued earlier today…
New York, NY, and Tel Aviv, ISRAEL, May 27, 2022 (GLOBE NEWSWIRE) — via NewMediaWire —Todos…
HALIFAX, Nova Scotia, May 27, 2022 (GLOBE NEWSWIRE) — Today, MedMira Inc. (MedMira) (TSXV: MIR)…
Efti in combination with pembrolizumab continues to show favourable antitumor activity in 1st line non-small…
– Ex vivo data support the high frequency of myeloid cells in tumors, even when…